Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vicki L Ellingrod

Showing results (1-10 of 102) with videos related to

Pageof 11
Sort By:
Therapeutic Drug Monitoring|May 22, 2002
C3435T mutation in exon 26 of the human MDR1 gene and cyclosporine pharmacokinetics in healthy subjectsDavid I Min, Vicki L Ellingrod
Pharmacotherapy|October 27, 2015
The Microbiome in Mental Health: Potential Contribution of Gut Microbiota in Disease and Pharmacotherapy ManagementStephanie A Flowers, Vicki L Ellingrod
Pharmacotherapy|August 25, 2017
Precision Pharmacotherapy Enables Precision MedicineJeffrey R Bishop, Vicki L Ellingrod
Pharmacogenomics|June 24, 2004
Neuropsychiatric pharmacogenetics: moving toward a comprehensive understanding of predicting risks and responseJeffrey R Bishop, Vicki L Ellingrod
Therapeutic Drug Monitoring|May 27, 2003
Association of the CYP3A4*1B 5'-flanking region polymorphism with cyclosporine pharmacokinetics in healthy subjectsDavid I Min, Vicki L Ellingrod
Molecular Diagnosis & Therapy|January 24, 2013
Detection of metabolic syndrome in schizophrenia and implications for antipsychotic therapy : is there a role for folate?Kyle J Burghardt, Vicki L Ellingrod
Pharmacotherapy|June 30, 2009
Pharmacogenetics of selective serotonin reuptake inhibitors and associated adverse drug reactionsKelan L H Thomas, Vicki L Ellingrod
Pharmacotherapy|November 16, 2002
Abnormal movements and tardive dyskinesia in smokers and nonsmokers with schizophrenia genotyped for cytochrome P450 2D6Vicki L Ellingrod, Susan K Schultz, Stephan Arndt
Psychopharmacology Bulletin|June 20, 2017
Sex Differences in Antipsychotic Related Metabolic Functioning in Schizophrenia Spectrum DisordersA Zarina Kraal, Kristen M Ward, Vicki L Ellingrod
Diabetes Care|July 25, 2023
Depressive Symptoms Longitudinally Mediate the Effect of Hyperglycemia on Memory Decline in Type 2 DiabetesA Zarina Kraal, Vicki L Ellingrod, Laura B Zahodne
Pageof 11

Showing results (1-10 of 102) with videos related to

Sort By:
Pageof 11
Therapeutic Drug Monitoring|May 22, 2002
C3435T mutation in exon 26 of the human MDR1 gene and cyclosporine pharmacokinetics in healthy subjectsDavid I Min, Vicki L Ellingrod
Pharmacotherapy|October 27, 2015
The Microbiome in Mental Health: Potential Contribution of Gut Microbiota in Disease and Pharmacotherapy ManagementStephanie A Flowers, Vicki L Ellingrod
Pharmacotherapy|August 25, 2017
Precision Pharmacotherapy Enables Precision MedicineJeffrey R Bishop, Vicki L Ellingrod
Pharmacogenomics|June 24, 2004
Neuropsychiatric pharmacogenetics: moving toward a comprehensive understanding of predicting risks and responseJeffrey R Bishop, Vicki L Ellingrod
Therapeutic Drug Monitoring|May 27, 2003
Association of the CYP3A4*1B 5'-flanking region polymorphism with cyclosporine pharmacokinetics in healthy subjectsDavid I Min, Vicki L Ellingrod
Molecular Diagnosis & Therapy|January 24, 2013
Detection of metabolic syndrome in schizophrenia and implications for antipsychotic therapy : is there a role for folate?Kyle J Burghardt, Vicki L Ellingrod
Pharmacotherapy|June 30, 2009
Pharmacogenetics of selective serotonin reuptake inhibitors and associated adverse drug reactionsKelan L H Thomas, Vicki L Ellingrod
Pharmacotherapy|November 16, 2002
Abnormal movements and tardive dyskinesia in smokers and nonsmokers with schizophrenia genotyped for cytochrome P450 2D6Vicki L Ellingrod, Susan K Schultz, Stephan Arndt
Psychopharmacology Bulletin|June 20, 2017
Sex Differences in Antipsychotic Related Metabolic Functioning in Schizophrenia Spectrum DisordersA Zarina Kraal, Kristen M Ward, Vicki L Ellingrod
Diabetes Care|July 25, 2023
Depressive Symptoms Longitudinally Mediate the Effect of Hyperglycemia on Memory Decline in Type 2 DiabetesA Zarina Kraal, Vicki L Ellingrod, Laura B Zahodne
Pageof 11